SIM
IONS icon

Sonora Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sonora Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$27K Buy
800
+100
+14% +$3.77K ﹤0.01% 550
2021
Q2 		$28K Buy
+700
New +$27.4K ﹤0.01% 503
2015
Q4 		– Sell
-25
Closed -$59K – 961
2015
Q3 		$59K Buy
+25
New +$1.29K 0.02% 199

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sonora Investment Management's IONS Position: Q3 2021 in Review

Sonora Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 2.9% in Q3 2021, selling an estimated $187K and leaving 163,703 shares worth $5.49M. The position accounts for 0.69% of the portfolio, ranked #56.

Sonora Investment Management first reported a position in IONS in Q3 2015 and has held it in 25 quarters since. The position peaked at $9.22M in Q1 2019. 325 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Sonora Investment Management held 163,703 shares of Ionis Pharmaceuticals worth $5.49M as of Q3 2021.
  • Sonora Investment Management sold 4,962 Ionis Pharmaceuticals shares in Q3 2021, an estimated $187K.
  • Ionis Pharmaceuticals made up 0.69% of Sonora Investment Management's portfolio in Q3 2021, its #56 holding.
  • Sonora Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
  • Sonora Investment Management's Ionis Pharmaceuticals position peaked at $9.22M in Q1 2019.
  • 325 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.